Insights into the biology of cord blood stem/progenitor cells

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 55-59

  Broxmeyer, H E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR;

ARTICLE; CELL EXPANSION; CELL FUNCTION; CELL HOMING; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; NEUTROPHIL; NONHUMAN; THROMBOCYTE;

ANIMALS; BLOOD BANKS; BLOOD PRESERVATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

ANIMALIA;

EID: 79953860776     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00728.x     Document Type: Article

References (38)

1. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178.
2. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D et al. (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828-3832.
3. Broxmeyer HE, Kurtzberg J, Gluckman E, Auerbach AD, Douglas G, Cooper S et al. (1991) Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 17, 313-329.
4. Broxmeyer HE (1997) Introduction: past, present and future of cord blood transplantation. In: Broxmeyer HE, ed. Cellular Characteristics of Cord Blood and Cord Blood Transplantation, pp. 1-11. Bethesda, MD, USA: Amer. Assoc. Blood Banking.
5. Broxmeyer HE (2000) Introduction. Cord blood transplantation: looking back and to the future. In: Cohen SBA, Gluckman E, Rubinstein P, Madrigal JA, eds. Cord Blood Characteristics: Role in Stem Cell Transplantation, pp. 1-12. London, UK: M. Dunitz.
6. Broxmeyer HE, Smith FO (2009) Cord blood hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' Hematopoietic Cell Transplantation, 4th edn, pp. 559-576. West Sussex, UK: Wiley-Blackwell.
7. Broxmeyer HE (2010) Umbilical cord blood transplantation: epilogue. In: Wagner JE, ed. Semin. Hematol. 47, 97-103.
8. Rocha V, Broxmeyer HE (2010) New approaches for improving engraftment after cord blood transplantation. Biol. Blood Marrow Transplant. 16, S126-S132.
9. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105, 1343-1347.
10. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110, 3064-3070.
11. Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E et al. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant. 13, 82-89.
12. Brunstein CG, Laughlin MJ (2010) Extending cord blood transplant to adults: dealing with problems and results overall. Semin. Hematol. 47, 86-96.
13. Broxmeyer HE, Cooper S, Hass DM, Hathaway JK, Stehman FB, Hangoc G (2009) Experimental basis of cord blood transplantation. Bone Marrow Transplant. 44, 627-633.
14. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett A et al. (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318.
15. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK (2005) The placenta is a niche for hematopoietic stem cells. Dev. Cell 8, 365-375.
16. Mikkola HK, Gekas C, Orkin SH, Dieterlen-Lievre F (2005) Placenta as a site for hematopoietic stem cell development. Exp. Hematol. 33, 1048-1054.
17. Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Chan DN et al. (2008) The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2, 252-263.
18. Robin C, Bollerot K, Mendes S, Haak E, Crisan M, Cerisoli F et al. (2009) Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 5, 385-395.
19. Shaheen M, Broxmeyer HE (2009) The humoral regulation of hematopoiesis. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop H, Anastasi J, eds. Hematology: Basic Principles and Practice, 5th edn. Part III, Chapter 24, pp. 253-275. Philadelphia, PA: Elsevier Churchill Livingston.
20. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID (2010) Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16, 232-236.
21. Campbell TB, Basu S, Hangoc G, Tao W, Broxmeyer HE (2009) Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation. Blood 114, 3392-3401.
22. Han M-K, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2, 241-251.
23. Mantel C, Messina-Graham S, Broxmeyer HE (2010) Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle 9, 1-10.
24. Dar A, Kollet O, Lapidot T (2006) Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp. Hematol. 34, 967-975.
25. Spiegel A, Kalinkovich A, Shivtiel S, Kollet O, Lapidot T (2008) Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell 3, 484-492.
26. Christopherson KW, Hangoc G, Broxmeyer HE (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J. Immunol. 169, 7000-7008.
27. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305, 1000-1003.
28. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW (2006) CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 108, 4268-4274.
29. Tian C, Bagley J, Forman D, Iacomini J (2006) Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13, 652-658.
30. Wyss BK, Donnelly AF, Zhou D, Sinn AL, Pollok KE, Goebel WS (2009) Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A. Exp. Hematol. 37, 814-823.
31. Campbell TB, Hangoc G, Liu Y, Pollok K, Broxmeyer HE (2007) Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev. 16, 347-354.
32. Christopherson KW, Paganessi LA, Napier S, Porecha NK (2007) CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice. Stem Cells Dev. 16, 355-360.
33. Kawai T, Choi U, Liu PC, Whiting-Theobald NL, Linton GF, Malech HL (2007) Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells. Stem Cells Dev. 16, 361-370.
34. Broxmeyer HE, Hoggatt J, Cooper S, Hangoc G, Pelus LM, Campbell TB (2009) CD26/Dipeptidylpeptidase IV regulates potency of selected hematopoietic growth factors through truncation, and recovery in vivo after cytotoxic stress. Blood 114, 3602.
35. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M et al. (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation of adults. Proc. Natl. Acad. Sci. USA 89, 4109-4113.
36. Broxmeyer HE, Cooper S (1997) High efficiency recovery of immature hematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for ten years. Clin. Exp. Immunol. 107, 45-53.
37. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM (2003) High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15years. Proc. Natl. Acad. Sci. USA 100, 645-650.
38. Broxmeyer HE (2010) Will iPS cells enhance therapeutic applicability of cord blood cells and banking? Cell Stem Cell 6, 21-24.